354793-04-7 Usage
Description
Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate is a heterocyclic chemical compound with the molecular formula C10H10N2O4. It features a ring structure composed of at least two different elements, making it a versatile compound in the fields of organic synthesis and pharmaceutical research.
Uses
Used in Pharmaceutical Research:
Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate is utilized as a key intermediate in the development of new drugs and pharmaceutical compounds due to its potential biological activities.
Used in Organic Synthesis:
Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate serves as a valuable building block in organic synthesis, contributing to the creation of various complex organic molecules.
Used in Antitumor Applications:
Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate is employed as an anti-tumor agent, leveraging its potential to combat cancer cells and contribute to cancer treatment.
Used in Anti-inflammatory Applications:
It is also used as an anti-inflammatory agent, potentially helping to reduce inflammation and associated symptoms in various conditions.
Overall, Methyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-carboxylate is a multifaceted chemical with a broad spectrum of potential applications in medicine and organic chemistry, making it a promising candidate for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 354793-04-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,4,7,9 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 354793-04:
(8*3)+(7*5)+(6*4)+(5*7)+(4*9)+(3*3)+(2*0)+(1*4)=167
167 % 10 = 7
So 354793-04-7 is a valid CAS Registry Number.
354793-04-7Relevant articles and documents
QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3K-BETA INHIBITORS
-
Page/Page column 78, (2018/10/25)
The present invent ion relates to substituted quinoxaline and pyridopyrazine derivatives of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present inv ention are useful as pI3Κβ inhibitors. The inv
Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines
-
Page/Page column 18, (2010/02/08)
The present invention provides compounds of formula (I) the prodrugs thereof, and the pharmaceutically acceptable salts of the compounds and prodrugs, wherein Ra, Rb, R1, and R2 are as defined herein; pharmaceutical compositions thereof; and uses thereof.
